Transcriptomics

Dataset Information

0

Secukinumab versus guselkumab in the complete treatment of ustekinumab‑resistant psoriatic plaques: ARROW


ABSTRACT: To investigate the clinical and molecular effects of direct IL-17A versus selective IL-23 inhibition in patients with anti-IL-12/23 refractory psoriatic plaques.

ORGANISM(S): Homo sapiens

PROVIDER: GSE197056 | GEO | 2023/06/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA808615 | ENA
2020-04-17 | GSE137510 | GEO
2021-03-26 | GSE137220 | GEO
2021-03-26 | GSE137218 | GEO
2021-02-23 | GSE167248 | GEO
2024-06-01 | GSE234831 | GEO
2022-12-02 | PXD036366 | Pride
2015-04-11 | E-GEOD-67762 | biostudies-arrayexpress
2015-08-20 | GSE72212 | GEO
2022-05-28 | GSE204832 | GEO